nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—SLC22A5—Dactinomycin—melanoma	0.271	0.367	CbGbCtD
Lomefloxacin—CYP1A2—Carmustine—melanoma	0.15	0.203	CbGbCtD
Lomefloxacin—CYP1A2—Vemurafenib—melanoma	0.119	0.16	CbGbCtD
Lomefloxacin—ABCC2—Docetaxel—melanoma	0.109	0.147	CbGbCtD
Lomefloxacin—CYP1A2—Dacarbazine—melanoma	0.0908	0.123	CbGbCtD
Lomefloxacin—TOP2A—Paclitaxel—Docetaxel—melanoma	0.0045	1	CbGdCrCtD
Lomefloxacin—Sweating increased—Temozolomide—melanoma	0.000676	0.00338	CcSEcCtD
Lomefloxacin—Decreased appetite—Vemurafenib—melanoma	0.000671	0.00336	CcSEcCtD
Lomefloxacin—Stomatitis—Dactinomycin—melanoma	0.000667	0.00334	CcSEcCtD
Lomefloxacin—Fatigue—Vemurafenib—melanoma	0.000666	0.00333	CcSEcCtD
Lomefloxacin—Constipation—Vemurafenib—melanoma	0.00066	0.0033	CcSEcCtD
Lomefloxacin—Pulmonary oedema—Docetaxel—melanoma	0.000655	0.00327	CcSEcCtD
Lomefloxacin—Dysuria—Temozolomide—melanoma	0.000649	0.00325	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Carmustine—melanoma	0.000648	0.00324	CcSEcCtD
Lomefloxacin—Agranulocytosis—Dactinomycin—melanoma	0.000638	0.00319	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Temozolomide—melanoma	0.000633	0.00317	CcSEcCtD
Lomefloxacin—Renal failure—Carmustine—melanoma	0.000629	0.00315	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Carmustine—melanoma	0.000628	0.00314	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Temozolomide—melanoma	0.000626	0.00313	CcSEcCtD
Lomefloxacin—Stomatitis—Carmustine—melanoma	0.000624	0.00312	CcSEcCtD
Lomefloxacin—Phlebitis—Docetaxel—melanoma	0.00062	0.0031	CcSEcCtD
Lomefloxacin—Hepatitis—Dactinomycin—melanoma	0.000614	0.00307	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000613	0.00307	CcSEcCtD
Lomefloxacin—Flushing—Bleomycin—melanoma	0.000611	0.00306	CcSEcCtD
Lomefloxacin—Pharyngitis—Dactinomycin—melanoma	0.000609	0.00305	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Temozolomide—melanoma	0.000606	0.00303	CcSEcCtD
Lomefloxacin—Stomatitis—Temozolomide—melanoma	0.000603	0.00302	CcSEcCtD
Lomefloxacin—Chills—Bleomycin—melanoma	0.000591	0.00296	CcSEcCtD
Lomefloxacin—Erythema multiforme—Dactinomycin—melanoma	0.000581	0.0029	CcSEcCtD
Lomefloxacin—Hallucination—Carmustine—melanoma	0.000572	0.00286	CcSEcCtD
Lomefloxacin—Hot flush—Docetaxel—melanoma	0.000571	0.00286	CcSEcCtD
Lomefloxacin—Flushing—Dactinomycin—melanoma	0.00057	0.00285	CcSEcCtD
Lomefloxacin—Hypersensitivity—Vemurafenib—melanoma	0.000569	0.00285	CcSEcCtD
Lomefloxacin—Menopausal symptoms—Docetaxel—melanoma	0.000566	0.00283	CcSEcCtD
Lomefloxacin—Dermatitis bullous—Docetaxel—melanoma	0.000559	0.00279	CcSEcCtD
Lomefloxacin—Hepatitis—Temozolomide—melanoma	0.000555	0.00278	CcSEcCtD
Lomefloxacin—Asthenia—Vemurafenib—melanoma	0.000554	0.00277	CcSEcCtD
Lomefloxacin—Visual impairment—Carmustine—melanoma	0.000554	0.00277	CcSEcCtD
Lomefloxacin—Hallucination—Temozolomide—melanoma	0.000553	0.00276	CcSEcCtD
Lomefloxacin—Pharyngitis—Temozolomide—melanoma	0.000551	0.00276	CcSEcCtD
Lomefloxacin—Chills—Dactinomycin—melanoma	0.000551	0.00276	CcSEcCtD
Lomefloxacin—Cardiac failure—Docetaxel—melanoma	0.000547	0.00274	CcSEcCtD
Lomefloxacin—Pruritus—Vemurafenib—melanoma	0.000546	0.00273	CcSEcCtD
Lomefloxacin—Visual impairment—Temozolomide—melanoma	0.000535	0.00268	CcSEcCtD
Lomefloxacin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000534	0.00267	CcSEcCtD
Lomefloxacin—Flushing—Carmustine—melanoma	0.000533	0.00267	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Bleomycin—melanoma	0.000532	0.00266	CcSEcCtD
Lomefloxacin—Anaemia—Bleomycin—melanoma	0.00053	0.00265	CcSEcCtD
Lomefloxacin—Diarrhoea—Vemurafenib—melanoma	0.000528	0.00264	CcSEcCtD
Lomefloxacin—Erythema multiforme—Temozolomide—melanoma	0.000525	0.00263	CcSEcCtD
Lomefloxacin—Tinnitus—Temozolomide—melanoma	0.000518	0.00259	CcSEcCtD
Lomefloxacin—Malaise—Bleomycin—melanoma	0.000517	0.00259	CcSEcCtD
Lomefloxacin—Flushing—Temozolomide—melanoma	0.000515	0.00258	CcSEcCtD
Lomefloxacin—Arrhythmia—Carmustine—melanoma	0.000513	0.00257	CcSEcCtD
Lomefloxacin—Leukopenia—Bleomycin—melanoma	0.000513	0.00257	CcSEcCtD
Lomefloxacin—Dizziness—Vemurafenib—melanoma	0.000511	0.00255	CcSEcCtD
Lomefloxacin—Ataxia—Docetaxel—melanoma	0.000502	0.00251	CcSEcCtD
Lomefloxacin—Cough—Bleomycin—melanoma	0.0005	0.0025	CcSEcCtD
Lomefloxacin—Chills—Temozolomide—melanoma	0.000498	0.00249	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Dactinomycin—melanoma	0.000496	0.00248	CcSEcCtD
Lomefloxacin—Anaemia—Dactinomycin—melanoma	0.000494	0.00247	CcSEcCtD
Lomefloxacin—Vomiting—Vemurafenib—melanoma	0.000491	0.00246	CcSEcCtD
Lomefloxacin—Gatifloxacin—ALB—melanoma	0.000489	0.403	CrCbGaD
Lomefloxacin—Chest pain—Bleomycin—melanoma	0.000488	0.00244	CcSEcCtD
Lomefloxacin—Myalgia—Bleomycin—melanoma	0.000488	0.00244	CcSEcCtD
Lomefloxacin—Rash—Vemurafenib—melanoma	0.000487	0.00244	CcSEcCtD
Lomefloxacin—Dermatitis—Vemurafenib—melanoma	0.000486	0.00243	CcSEcCtD
Lomefloxacin—Back pain—Carmustine—melanoma	0.000484	0.00242	CcSEcCtD
Lomefloxacin—Headache—Vemurafenib—melanoma	0.000484	0.00242	CcSEcCtD
Lomefloxacin—Discomfort—Bleomycin—melanoma	0.000482	0.00241	CcSEcCtD
Lomefloxacin—Malaise—Dactinomycin—melanoma	0.000482	0.00241	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000481	0.00241	CcSEcCtD
Lomefloxacin—Leukopenia—Dactinomycin—melanoma	0.000478	0.00239	CcSEcCtD
Lomefloxacin—Dysgeusia—Temozolomide—melanoma	0.000473	0.00237	CcSEcCtD
Lomefloxacin—Confusional state—Bleomycin—melanoma	0.000472	0.00236	CcSEcCtD
Lomefloxacin—Tremor—Carmustine—melanoma	0.000469	0.00234	CcSEcCtD
Lomefloxacin—Oedema—Bleomycin—melanoma	0.000468	0.00234	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Bleomycin—melanoma	0.000468	0.00234	CcSEcCtD
Lomefloxacin—Back pain—Temozolomide—melanoma	0.000468	0.00234	CcSEcCtD
Lomefloxacin—Anaemia—Carmustine—melanoma	0.000462	0.00231	CcSEcCtD
Lomefloxacin—Dysphagia—Docetaxel—melanoma	0.000461	0.00231	CcSEcCtD
Lomefloxacin—Agitation—Carmustine—melanoma	0.00046	0.0023	CcSEcCtD
Lomefloxacin—Nausea—Vemurafenib—melanoma	0.000459	0.00229	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Bleomycin—melanoma	0.000458	0.00229	CcSEcCtD
Lomefloxacin—Myalgia—Dactinomycin—melanoma	0.000455	0.00228	CcSEcCtD
Lomefloxacin—Bronchospasm—Docetaxel—melanoma	0.000454	0.00227	CcSEcCtD
Lomefloxacin—Tremor—Temozolomide—melanoma	0.000453	0.00227	CcSEcCtD
Lomefloxacin—Discomfort—Dactinomycin—melanoma	0.00045	0.00225	CcSEcCtD
Lomefloxacin—Angina pectoris—Docetaxel—melanoma	0.000449	0.00225	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Temozolomide—melanoma	0.000449	0.00224	CcSEcCtD
Lomefloxacin—Leukopenia—Carmustine—melanoma	0.000448	0.00224	CcSEcCtD
Lomefloxacin—Anaemia—Temozolomide—melanoma	0.000447	0.00224	CcSEcCtD
Lomefloxacin—Anorexia—Bleomycin—melanoma	0.000446	0.00223	CcSEcCtD
Lomefloxacin—Agitation—Temozolomide—melanoma	0.000444	0.00222	CcSEcCtD
Lomefloxacin—Angioedema—Temozolomide—melanoma	0.000442	0.00221	CcSEcCtD
Lomefloxacin—Hypotension—Bleomycin—melanoma	0.000437	0.00219	CcSEcCtD
Lomefloxacin—Oedema—Dactinomycin—melanoma	0.000436	0.00218	CcSEcCtD
Lomefloxacin—Malaise—Temozolomide—melanoma	0.000436	0.00218	CcSEcCtD
Lomefloxacin—Vertigo—Temozolomide—melanoma	0.000434	0.00217	CcSEcCtD
Lomefloxacin—Convulsion—Carmustine—melanoma	0.000433	0.00217	CcSEcCtD
Lomefloxacin—Leukopenia—Temozolomide—melanoma	0.000433	0.00216	CcSEcCtD
Lomefloxacin—Hypertension—Carmustine—melanoma	0.000432	0.00216	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Dactinomycin—melanoma	0.000427	0.00214	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000426	0.00213	CcSEcCtD
Lomefloxacin—Myalgia—Carmustine—melanoma	0.000426	0.00213	CcSEcCtD
Lomefloxacin—Chest pain—Carmustine—melanoma	0.000426	0.00213	CcSEcCtD
Lomefloxacin—Anxiety—Carmustine—melanoma	0.000424	0.00212	CcSEcCtD
Lomefloxacin—Cough—Temozolomide—melanoma	0.000422	0.00211	CcSEcCtD
Lomefloxacin—Paraesthesia—Bleomycin—melanoma	0.00042	0.0021	CcSEcCtD
Lomefloxacin—Convulsion—Temozolomide—melanoma	0.000419	0.0021	CcSEcCtD
Lomefloxacin—Hypertension—Temozolomide—melanoma	0.000417	0.00209	CcSEcCtD
Lomefloxacin—Dyspnoea—Bleomycin—melanoma	0.000417	0.00209	CcSEcCtD
Lomefloxacin—Anorexia—Dactinomycin—melanoma	0.000416	0.00208	CcSEcCtD
Lomefloxacin—Confusional state—Carmustine—melanoma	0.000412	0.00206	CcSEcCtD
Lomefloxacin—Arthralgia—Temozolomide—melanoma	0.000412	0.00206	CcSEcCtD
Lomefloxacin—Myalgia—Temozolomide—melanoma	0.000412	0.00206	CcSEcCtD
Lomefloxacin—Anxiety—Temozolomide—melanoma	0.00041	0.00205	CcSEcCtD
Lomefloxacin—Oedema—Carmustine—melanoma	0.000408	0.00204	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000408	0.00204	CcSEcCtD
Lomefloxacin—Discomfort—Temozolomide—melanoma	0.000407	0.00203	CcSEcCtD
Lomefloxacin—Decreased appetite—Bleomycin—melanoma	0.000407	0.00203	CcSEcCtD
Lomefloxacin—Acute coronary syndrome—Docetaxel—melanoma	0.000406	0.00203	CcSEcCtD
Lomefloxacin—Renal failure—Docetaxel—melanoma	0.000404	0.00202	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Docetaxel—melanoma	0.000403	0.00202	CcSEcCtD
Lomefloxacin—Myocardial infarction—Docetaxel—melanoma	0.000403	0.00202	CcSEcCtD
Lomefloxacin—Dry mouth—Temozolomide—melanoma	0.000403	0.00201	CcSEcCtD
Lomefloxacin—Stomatitis—Docetaxel—melanoma	0.000401	0.00201	CcSEcCtD
Lomefloxacin—Conjunctivitis—Docetaxel—melanoma	0.0004	0.002	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Carmustine—melanoma	0.0004	0.002	CcSEcCtD
Lomefloxacin—Tachycardia—Carmustine—melanoma	0.000398	0.00199	CcSEcCtD
Lomefloxacin—Confusional state—Temozolomide—melanoma	0.000398	0.00199	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000397	0.00199	CcSEcCtD
Lomefloxacin—Oedema—Temozolomide—melanoma	0.000395	0.00197	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Temozolomide—melanoma	0.000395	0.00197	CcSEcCtD
Lomefloxacin—Anorexia—Carmustine—melanoma	0.000389	0.00195	CcSEcCtD
Lomefloxacin—Epistaxis—Docetaxel—melanoma	0.000388	0.00194	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Temozolomide—melanoma	0.000386	0.00193	CcSEcCtD
Lomefloxacin—Feeling abnormal—Bleomycin—melanoma	0.000385	0.00193	CcSEcCtD
Lomefloxacin—Agranulocytosis—Docetaxel—melanoma	0.000384	0.00192	CcSEcCtD
Lomefloxacin—Skin disorder—Temozolomide—melanoma	0.000383	0.00192	CcSEcCtD
Lomefloxacin—Hypotension—Carmustine—melanoma	0.000382	0.00191	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Temozolomide—melanoma	0.000381	0.00191	CcSEcCtD
Lomefloxacin—Decreased appetite—Dactinomycin—melanoma	0.000379	0.0019	CcSEcCtD
Lomefloxacin—Fatigue—Dactinomycin—melanoma	0.000376	0.00188	CcSEcCtD
Lomefloxacin—Anorexia—Temozolomide—melanoma	0.000376	0.00188	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Carmustine—melanoma	0.000372	0.00186	CcSEcCtD
Lomefloxacin—Urticaria—Bleomycin—melanoma	0.000372	0.00186	CcSEcCtD
Lomefloxacin—Rhinitis—Docetaxel—melanoma	0.00037	0.00185	CcSEcCtD
Lomefloxacin—Hepatitis—Docetaxel—melanoma	0.000369	0.00185	CcSEcCtD
Lomefloxacin—Insomnia—Carmustine—melanoma	0.000369	0.00185	CcSEcCtD
Lomefloxacin—Paraesthesia—Carmustine—melanoma	0.000367	0.00183	CcSEcCtD
Lomefloxacin—Pharyngitis—Docetaxel—melanoma	0.000367	0.00183	CcSEcCtD
Lomefloxacin—Dyspnoea—Carmustine—melanoma	0.000364	0.00182	CcSEcCtD
Lomefloxacin—Somnolence—Carmustine—melanoma	0.000363	0.00182	CcSEcCtD
Lomefloxacin—Feeling abnormal—Dactinomycin—melanoma	0.000359	0.0018	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000359	0.0018	CcSEcCtD
Lomefloxacin—Insomnia—Temozolomide—melanoma	0.000357	0.00179	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Dactinomycin—melanoma	0.000357	0.00178	CcSEcCtD
Lomefloxacin—Visual impairment—Docetaxel—melanoma	0.000356	0.00178	CcSEcCtD
Lomefloxacin—Decreased appetite—Carmustine—melanoma	0.000355	0.00178	CcSEcCtD
Lomefloxacin—Paraesthesia—Temozolomide—melanoma	0.000354	0.00177	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—melanoma	0.000352	0.00643	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Temozolomide—melanoma	0.000352	0.00176	CcSEcCtD
Lomefloxacin—Somnolence—Temozolomide—melanoma	0.000351	0.00175	CcSEcCtD
Lomefloxacin—Erythema multiforme—Docetaxel—melanoma	0.000349	0.00175	CcSEcCtD
Lomefloxacin—Constipation—Carmustine—melanoma	0.000349	0.00175	CcSEcCtD
Lomefloxacin—Dyspepsia—Temozolomide—melanoma	0.000347	0.00174	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.000346	0.00631	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.000346	0.00631	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Dactinomycin—melanoma	0.000345	0.00173	CcSEcCtD
Lomefloxacin—Hypersensitivity—Bleomycin—melanoma	0.000345	0.00172	CcSEcCtD
Lomefloxacin—Decreased appetite—Temozolomide—melanoma	0.000343	0.00172	CcSEcCtD
Lomefloxacin—Flushing—Docetaxel—melanoma	0.000343	0.00171	CcSEcCtD
Lomefloxacin—Fatigue—Temozolomide—melanoma	0.00034	0.0017	CcSEcCtD
Lomefloxacin—Constipation—Temozolomide—melanoma	0.000337	0.00169	CcSEcCtD
Lomefloxacin—Feeling abnormal—Carmustine—melanoma	0.000336	0.00168	CcSEcCtD
Lomefloxacin—Asthenia—Bleomycin—melanoma	0.000336	0.00168	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Carmustine—melanoma	0.000334	0.00167	CcSEcCtD
Lomefloxacin—Chills—Docetaxel—melanoma	0.000331	0.00166	CcSEcCtD
Lomefloxacin—Pruritus—Bleomycin—melanoma	0.000331	0.00166	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—melanoma	0.00033	0.00603	CbGpPWpGaD
Lomefloxacin—Arrhythmia—Docetaxel—melanoma	0.00033	0.00165	CcSEcCtD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000325	0.00594	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Temozolomide—melanoma	0.000325	0.00163	CcSEcCtD
Lomefloxacin—Abdominal pain—Carmustine—melanoma	0.000323	0.00161	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Temozolomide—melanoma	0.000323	0.00161	CcSEcCtD
Lomefloxacin—Hypersensitivity—Dactinomycin—melanoma	0.000321	0.00161	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.00032	0.00583	CbGpPWpGaD
Lomefloxacin—Dysgeusia—Docetaxel—melanoma	0.000315	0.00158	CcSEcCtD
Lomefloxacin—Urticaria—Temozolomide—melanoma	0.000313	0.00157	CcSEcCtD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—melanoma	0.000313	0.00572	CbGpPWpGaD
Lomefloxacin—Asthenia—Dactinomycin—melanoma	0.000313	0.00157	CcSEcCtD
Lomefloxacin—Abdominal pain—Temozolomide—melanoma	0.000312	0.00156	CcSEcCtD
Lomefloxacin—Back pain—Docetaxel—melanoma	0.000311	0.00156	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00031	0.00566	CbGpPWpGaD
Lomefloxacin—Muscle spasms—Docetaxel—melanoma	0.000309	0.00155	CcSEcCtD
Lomefloxacin—Sparfloxacin—ABCB1—melanoma	0.000305	0.251	CrCbGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—melanoma	0.000302	0.00551	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Carmustine—melanoma	0.000301	0.0015	CcSEcCtD
Lomefloxacin—Diarrhoea—Dactinomycin—melanoma	0.000298	0.00149	CcSEcCtD
Lomefloxacin—Vomiting—Bleomycin—melanoma	0.000297	0.00149	CcSEcCtD
Lomefloxacin—Anaemia—Docetaxel—melanoma	0.000297	0.00149	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—melanoma	0.000296	0.0054	CbGpPWpGaD
Lomefloxacin—Rash—Bleomycin—melanoma	0.000295	0.00148	CcSEcCtD
Lomefloxacin—Dermatitis—Bleomycin—melanoma	0.000295	0.00147	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.000294	0.00537	CbGpPWpGaD
Lomefloxacin—Asthenia—Carmustine—melanoma	0.000293	0.00147	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—melanoma	0.000293	0.00534	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—REC8—melanoma	0.000292	0.00534	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000292	0.00532	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Temozolomide—melanoma	0.000291	0.00145	CcSEcCtD
Lomefloxacin—Syncope—Docetaxel—melanoma	0.000288	0.00144	CcSEcCtD
Lomefloxacin—Leukopenia—Docetaxel—melanoma	0.000288	0.00144	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—MYC—melanoma	0.000285	0.00521	CbGpPWpGaD
Lomefloxacin—Asthenia—Temozolomide—melanoma	0.000283	0.00142	CcSEcCtD
Lomefloxacin—Loss of consciousness—Docetaxel—melanoma	0.000283	0.00141	CcSEcCtD
Lomefloxacin—Cough—Docetaxel—melanoma	0.000281	0.0014	CcSEcCtD
Lomefloxacin—Diarrhoea—Carmustine—melanoma	0.000279	0.0014	CcSEcCtD
Lomefloxacin—Pruritus—Temozolomide—melanoma	0.000279	0.0014	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—melanoma	0.000279	0.00509	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—melanoma	0.000279	0.00509	CbGpPWpGaD
Lomefloxacin—Convulsion—Docetaxel—melanoma	0.000279	0.00139	CcSEcCtD
Lomefloxacin—Nausea—Bleomycin—melanoma	0.000278	0.00139	CcSEcCtD
Lomefloxacin—Hypertension—Docetaxel—melanoma	0.000278	0.00139	CcSEcCtD
Lomefloxacin—Vomiting—Dactinomycin—melanoma	0.000277	0.00139	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ARL2—melanoma	0.000276	0.00505	CbGpPWpGaD
Lomefloxacin—Rash—Dactinomycin—melanoma	0.000275	0.00138	CcSEcCtD
Lomefloxacin—Arthralgia—Docetaxel—melanoma	0.000274	0.00137	CcSEcCtD
Lomefloxacin—Myalgia—Docetaxel—melanoma	0.000274	0.00137	CcSEcCtD
Lomefloxacin—Chest pain—Docetaxel—melanoma	0.000274	0.00137	CcSEcCtD
Lomefloxacin—Dizziness—Carmustine—melanoma	0.00027	0.00135	CcSEcCtD
Lomefloxacin—Diarrhoea—Temozolomide—melanoma	0.00027	0.00135	CcSEcCtD
Lomefloxacin—Dry mouth—Docetaxel—melanoma	0.000268	0.00134	CcSEcCtD
Lomefloxacin—Confusional state—Docetaxel—melanoma	0.000265	0.00132	CcSEcCtD
Lomefloxacin—Oedema—Docetaxel—melanoma	0.000262	0.00131	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Docetaxel—melanoma	0.000262	0.00131	CcSEcCtD
Lomefloxacin—Dizziness—Temozolomide—melanoma	0.000261	0.00131	CcSEcCtD
Lomefloxacin—Vomiting—Carmustine—melanoma	0.00026	0.0013	CcSEcCtD
Lomefloxacin—Nausea—Dactinomycin—melanoma	0.000259	0.0013	CcSEcCtD
Lomefloxacin—Shock—Docetaxel—melanoma	0.000258	0.00129	CcSEcCtD
Lomefloxacin—Rash—Carmustine—melanoma	0.000257	0.00129	CcSEcCtD
Lomefloxacin—Dermatitis—Carmustine—melanoma	0.000257	0.00129	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Docetaxel—melanoma	0.000257	0.00129	CcSEcCtD
Lomefloxacin—Tachycardia—Docetaxel—melanoma	0.000256	0.00128	CcSEcCtD
Lomefloxacin—Headache—Carmustine—melanoma	0.000256	0.00128	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—melanoma	0.000255	0.00466	CbGpPWpGaD
Lomefloxacin—Skin disorder—Docetaxel—melanoma	0.000255	0.00128	CcSEcCtD
Lomefloxacin—Vomiting—Temozolomide—melanoma	0.000251	0.00126	CcSEcCtD
Lomefloxacin—Anorexia—Docetaxel—melanoma	0.00025	0.00125	CcSEcCtD
Lomefloxacin—Rash—Temozolomide—melanoma	0.000249	0.00124	CcSEcCtD
Lomefloxacin—Dermatitis—Temozolomide—melanoma	0.000249	0.00124	CcSEcCtD
Lomefloxacin—Headache—Temozolomide—melanoma	0.000247	0.00124	CcSEcCtD
Lomefloxacin—Hypotension—Docetaxel—melanoma	0.000245	0.00123	CcSEcCtD
Lomefloxacin—Nausea—Carmustine—melanoma	0.000243	0.00121	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—melanoma	0.000242	0.00442	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.000241	0.0044	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PKMYT1—melanoma	0.00024	0.00438	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—INCENP—melanoma	0.00024	0.00438	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000239	0.0012	CcSEcCtD
Lomefloxacin—Insomnia—Docetaxel—melanoma	0.000237	0.00119	CcSEcCtD
Lomefloxacin—Paraesthesia—Docetaxel—melanoma	0.000236	0.00118	CcSEcCtD
Lomefloxacin—Nausea—Temozolomide—melanoma	0.000234	0.00117	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—melanoma	0.000234	0.00428	CbGpPWpGaD
Lomefloxacin—Dyspnoea—Docetaxel—melanoma	0.000234	0.00117	CcSEcCtD
Lomefloxacin—Somnolence—Docetaxel—melanoma	0.000233	0.00117	CcSEcCtD
Lomefloxacin—Dyspepsia—Docetaxel—melanoma	0.000231	0.00116	CcSEcCtD
Lomefloxacin—Decreased appetite—Docetaxel—melanoma	0.000228	0.00114	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.000227	0.00414	CbGpPWpGaD
Lomefloxacin—Fatigue—Docetaxel—melanoma	0.000226	0.00113	CcSEcCtD
Lomefloxacin—Constipation—Docetaxel—melanoma	0.000224	0.00112	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—GNA11—melanoma	0.00022	0.00401	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Docetaxel—melanoma	0.000216	0.00108	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PKMYT1—melanoma	0.000215	0.00392	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—INCENP—melanoma	0.000215	0.00392	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Docetaxel—melanoma	0.000215	0.00107	CcSEcCtD
Lomefloxacin—Levofloxacin—ABCB1—melanoma	0.000214	0.176	CrCbGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.00021	0.00383	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000209	0.00382	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—melanoma	0.000208	0.0038	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—UGT2B10—melanoma	0.000208	0.00379	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Docetaxel—melanoma	0.000207	0.00104	CcSEcCtD
Lomefloxacin—Ciprofloxacin—ABCB1—melanoma	0.000207	0.17	CrCbGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—HDAC2—melanoma	0.000206	0.00377	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—GNAQ—melanoma	0.000204	0.00373	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ARL2—melanoma	0.000202	0.00369	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000202	0.00368	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—melanoma	0.000196	0.00358	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—melanoma	0.000196	0.00357	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Docetaxel—melanoma	0.000193	0.000967	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—SLC5A5—melanoma	0.000191	0.00349	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NGFR—melanoma	0.000188	0.00344	CbGpPWpGaD
Lomefloxacin—Asthenia—Docetaxel—melanoma	0.000188	0.000942	CcSEcCtD
Lomefloxacin—Pruritus—Docetaxel—melanoma	0.000186	0.000929	CcSEcCtD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—PRKCA—melanoma	0.000183	0.00335	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000183	0.00334	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—POT1—melanoma	0.000181	0.0033	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Docetaxel—melanoma	0.00018	0.000898	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—melanoma	0.00018	0.00328	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000179	0.00326	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000176	0.0032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000175	0.0032	CbGpPWpGaD
Lomefloxacin—Dizziness—Docetaxel—melanoma	0.000174	0.000868	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000172	0.00314	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—melanoma	0.00017	0.0031	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000168	0.00306	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—melanoma	0.000167	0.00306	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—melanoma	0.000167	0.00306	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	0.000167	0.00306	CbGpPWpGaD
Lomefloxacin—Vomiting—Docetaxel—melanoma	0.000167	0.000835	CcSEcCtD
Lomefloxacin—Rash—Docetaxel—melanoma	0.000165	0.000828	CcSEcCtD
Lomefloxacin—Dermatitis—Docetaxel—melanoma	0.000165	0.000827	CcSEcCtD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000165	0.00301	CbGpPWpGaD
Lomefloxacin—Headache—Docetaxel—melanoma	0.000164	0.000822	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000163	0.00298	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—melanoma	0.000162	0.00295	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000161	0.00294	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000161	0.00293	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000159	0.0029	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000158	0.00288	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—melanoma	0.000157	0.00286	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000156	0.00285	CbGpPWpGaD
Lomefloxacin—Nausea—Docetaxel—melanoma	0.000156	0.00078	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000156	0.00284	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000154	0.00282	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000153	0.0028	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000151	0.00277	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000151	0.00275	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000149	0.00271	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—melanoma	0.000148	0.00269	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000147	0.00269	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000146	0.00267	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000143	0.00261	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HGF—melanoma	0.000141	0.00258	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—FAS—melanoma	0.00014	0.00256	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000136	0.00248	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000135	0.00247	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000134	0.00244	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000134	0.00244	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—AKR1B10—melanoma	0.000132	0.00241	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00013	0.00238	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.00013	0.00237	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—melanoma	0.000129	0.00236	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000129	0.00236	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000129	0.00235	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000125	0.00228	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CDK4—melanoma	0.000123	0.00225	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000122	0.00223	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—melanoma	0.000121	0.00221	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000121	0.00221	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NOS2—melanoma	0.00012	0.00219	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00012	0.00218	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000115	0.0021	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000113	0.00206	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—melanoma	0.000112	0.00205	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	0.000112	0.00204	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000111	0.00202	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—melanoma	0.000111	0.00202	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.00011	0.002	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—melanoma	0.00011	0.002	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MLH1—melanoma	0.000109	0.002	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—SKP2—melanoma	0.000108	0.00198	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000107	0.00195	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000106	0.00194	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000103	0.00187	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000102	0.00186	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—AURKA—melanoma	9.9e-05	0.00181	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	9.67e-05	0.00177	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—melanoma	9.62e-05	0.00176	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	9.53e-05	0.00174	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	9.47e-05	0.00173	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	9.4e-05	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	9.19e-05	0.00168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	9.18e-05	0.00168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	8.79e-05	0.00161	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—melanoma	8.79e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	8.72e-05	0.00159	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	8.7e-05	0.00159	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—APEX1—melanoma	8.6e-05	0.00157	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	8.53e-05	0.00156	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	8.37e-05	0.00153	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—melanoma	8.32e-05	0.00152	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	8.3e-05	0.00152	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	8.22e-05	0.0015	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	8.03e-05	0.00147	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	8.01e-05	0.00146	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	7.97e-05	0.00146	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	7.87e-05	0.00144	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	7.86e-05	0.00143	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—MDM2—melanoma	7.82e-05	0.00143	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—melanoma	7.69e-05	0.0014	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—melanoma	7.63e-05	0.00139	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	7.54e-05	0.00138	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PRKCA—melanoma	7.48e-05	0.00137	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2B—melanoma	7.44e-05	0.00136	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	7.24e-05	0.00132	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—melanoma	7.2e-05	0.00131	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	7.14e-05	0.0013	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	7.14e-05	0.0013	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	7.06e-05	0.00129	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	6.99e-05	0.00128	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP17A1—melanoma	6.92e-05	0.00126	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	6.85e-05	0.00125	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	6.83e-05	0.00125	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—E2F1—melanoma	6.83e-05	0.00125	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PRKCA—melanoma	6.69e-05	0.00122	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—melanoma	6.66e-05	0.00122	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	6.59e-05	0.0012	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—melanoma	6.58e-05	0.0012	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	6.55e-05	0.0012	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	6.51e-05	0.00119	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	6.51e-05	0.00119	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PCNA—melanoma	6.44e-05	0.00118	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	6.38e-05	0.00117	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—melanoma	6.22e-05	0.00114	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TERT—melanoma	6.22e-05	0.00113	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—melanoma	6.2e-05	0.00113	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	6.15e-05	0.00112	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	6.12e-05	0.00112	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	5.94e-05	0.00108	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK2—melanoma	5.89e-05	0.00107	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	5.87e-05	0.00107	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP1B1—melanoma	5.83e-05	0.00106	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	5.75e-05	0.00105	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	5.65e-05	0.00103	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—ATM—melanoma	5.59e-05	0.00102	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK4—melanoma	5.56e-05	0.00102	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—melanoma	5.47e-05	0.000998	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	5.47e-05	0.000998	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—melanoma	5.41e-05	0.000988	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	5.35e-05	0.000976	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	5.35e-05	0.000976	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	5.35e-05	0.000976	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	5.28e-05	0.000965	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—melanoma	5.25e-05	0.000958	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	5.09e-05	0.00093	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	5.09e-05	0.00093	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	5.05e-05	0.000922	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RB1—melanoma	4.84e-05	0.000883	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—melanoma	4.8e-05	0.000877	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—melanoma	4.76e-05	0.000868	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	4.67e-05	0.000852	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.62e-05	0.000843	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	4.41e-05	0.000805	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	4.29e-05	0.000784	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—melanoma	4.25e-05	0.000776	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—melanoma	4.21e-05	0.000769	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	4.13e-05	0.000753	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MDM2—melanoma	4.13e-05	0.000753	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—melanoma	4.02e-05	0.000734	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	3.99e-05	0.000729	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—melanoma	3.89e-05	0.00071	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACER3—melanoma	3.88e-05	0.000709	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—melanoma	3.77e-05	0.000688	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—melanoma	3.59e-05	0.000656	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UGT2B10—melanoma	3.55e-05	0.000649	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.51e-05	0.00064	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1A—melanoma	3.48e-05	0.000635	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—melanoma	3.31e-05	0.000605	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HS3ST5—melanoma	3.3e-05	0.000603	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—melanoma	3.22e-05	0.000588	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—melanoma	3.15e-05	0.000576	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—melanoma	2.96e-05	0.000541	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	2.92e-05	0.000533	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—melanoma	2.88e-05	0.000526	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK1—melanoma	2.82e-05	0.000515	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.66e-05	0.000485	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLCB4—melanoma	2.5e-05	0.000457	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.46e-05	0.000449	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—melanoma	2.37e-05	0.000432	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC6A11—melanoma	2.35e-05	0.00043	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIP4K2A—melanoma	2.35e-05	0.00043	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTAP—melanoma	2.29e-05	0.000418	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.24e-05	0.000408	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LUM—melanoma	2.04e-05	0.000373	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PHGDH—melanoma	2.04e-05	0.000373	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HPSE—melanoma	2e-05	0.000365	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CUBN—melanoma	1.96e-05	0.000359	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SDHD—melanoma	1.9e-05	0.000346	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BSG—melanoma	1.9e-05	0.000346	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CSPG4—melanoma	1.9e-05	0.000346	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPAM—melanoma	1.84e-05	0.000335	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLA2G6—melanoma	1.56e-05	0.000285	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—VCAN—melanoma	1.4e-05	0.000256	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.33e-05	0.000242	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.28e-05	0.000234	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP17A1—melanoma	1.18e-05	0.000216	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.17e-05	0.000213	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.15e-05	0.00021	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GNA11—melanoma	1.12e-05	0.000204	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FASN—melanoma	1.09e-05	0.0002	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A5—melanoma	1.08e-05	0.000196	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GNAQ—melanoma	1.04e-05	0.00019	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CD44—melanoma	1.04e-05	0.00019	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.02e-05	0.000186	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.01e-05	0.000184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP1B1—melanoma	9.96e-06	0.000182	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.79e-06	0.000161	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—melanoma	8.21e-06	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PRKCA—melanoma	7.55e-06	0.000138	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ERCC2—melanoma	7.49e-06	0.000137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.2e-06	0.000113	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—melanoma	5.92e-06	0.000108	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—melanoma	5.71e-06	0.000104	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CD—melanoma	5.2e-06	9.49e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—melanoma	5.13e-06	9.37e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CB—melanoma	4.53e-06	8.27e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—melanoma	4.49e-06	8.2e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—melanoma	3.92e-06	7.15e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—melanoma	2.76e-06	5.04e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—melanoma	2.26e-06	4.12e-05	CbGpPWpGaD
